Showing posts with label Canadian Institutes of Health Research. Show all posts
Showing posts with label Canadian Institutes of Health Research. Show all posts

Sunday

Canadian Government Supports Health Care Innovation in Ontario

Single-Largest Investor in Canadian Health Innovation

TORONTO, July 20, 2012 /Canada NewsWire/ - Eve Adams, MP for Mississauga - Brampton South, visited Holland Bloorview Kids Rehabilitation Hospital today with her son, Jeffrey. She highlighted how federal investments are helping strengthen healthcare across the country. MP Adams joined other members of the Canadian Government who made similar visits with health researchers across the country.

"Our Government is proud to support the outstanding health researchers at Holland Bloorview," said MP Eve Adams. "I was delighted to meet with these researchers and find out how their work is helping to improve the wellbeing of children visiting the hospital."

There are more than 10,000 health research projects underway in Canada right now that receive Canadian Government funding. Some recent initiatives announced include:

...Pathways to Health Equity for Aboriginal Peoples, in which researchers will partner with aboriginal communities to carry out initiatives linked to suicide reduction and other key health priorities;

...Funding 13 projects to improve the efficiency of front-line healthcare delivery, whose results will be available for provincial and territorial governments to use to strengthen their systems; and

...Funding for a national transplantation research program.

MP Eve Adams met with Dr. Elaine A. Biddiss and her colleagues. Dr. Biddiss is studying the effect of interactive media experience in a children's hospital clinic waiting area.

"Waiting to see a doctor or clinician can often make a child apprehensive or bored. Traditional waiting rooms provide toys for children to play with but they are often not accessible to children with disabilities who may not have the dexterity or mobility needed to play with them" says Elaine Biddiss, scientist, Bloorview Research Institute. "The CIHR grant has given us the opportunity to study the impact of an interactive and inclusive waiting room that features a large-scale projection wall that children can interact with via a pressure-sensitive floor."

Federal support for health research primarily flows through its health research investment agency - the Canadian Institutes of Health Research (CIHR). CIHR supports the best in peer-reviewed health research with the vision of creating a healthier future for Canadians.

"Canadian health researchers across all research disciplines and themes continue to have a significant impact on the country's international scientific excellence and competitiveness," said Dr. Alain Beaudet, President of CIHR. "At CIHR, we prize the many achievements and contributions our researchers make to resolving pressing health challenges and to improving the health outcomes of patients and supporting a robust and sustainable health care system."

Since 2006-05, the Government has invested $2.2 billion in health research in Ontario through CIHR.

Thursday

University of Guelph Research May Improve Life After Heart Attack

GUELPH Ontario June 06, 2012 - University of Guelph News Release - A way to help more patients survive and enjoy healthier lives after a heart attack may be a step closer with a new study by researchers in the University of Guelph’s Ontario Veterinary College (OVC).

Prof. Glen Pyle, Biomedical Sciences, and former grad student Feng Hua Yang found that lower levels of a heart muscle protein in transgenic mice can help protect against damage sustained during and after a heart attack.

This is the first study showing benefits of lower CapZ protein in the heart. The protein is involved in cell signalling in the heart.

“We’ve identified a unique target,” said Pyle. Only one other research group – his former post-doc lab in Chicago – is looking at this particular protein. “We know that targeting the protein is a benefit.”

The paper appeared recently in the Journal of Molecular and Cellular Cardiology.

Their work might help in developing better therapies for treating heart attack patients, said Pyle. Lowering CapZ would not necessarily prevent heart attacks but may help protect against subsequent damage to the muscle.

A lot of damage comes from when you restart the heart,” he said. That damage may be acute or it may be chronic for patients with heart failure resulting from a heart attack. Heart failure may also be caused by such conditions as diabetes or high blood pressure.

Pyle said doctors might eventually inject patients with peptides, or short stretches of protein, that bind and disable certain heart proteins. Peptide therapy might better target CapZ proteins than existing drugs with more wide-ranging effects.

The Guelph researchers used transgenic mice to study CapZ.

In the heart, the protein plays a structural role, but it is also involved in responding to physical stretching and straining during a heart attack.

Pyle plans to continue studies of how the protein works and how to manipulate it.

Besides benefiting human patients, he hopes his work will help animals such as Doberman pinschers, which are susceptible to heart disease.

“We will look for this protein in their heart and see the effects. The same peptide and gene therapies could apply in dogs.”

Pyle belongs to a cross-campus research group looking at heart disease from molecules to whole animals.

This study was supported by the Canadian Institutes of Health Research, a Premier’s Research Excellence Award, and the Heart and Stroke Foundation of Canada.

Friday

Challenges with movement only half the story in Parkinson’s


TORONTO, March 21, 2012 - People with Parkinson’s disease have a new tool to help them identify the non-motor symptoms they are experiencing with their Parkinson’s disease.

A Guide to the Non-Motor Symptoms of Parkinson’s Disease, the first of its kind in Canada, is a user-friendly, educational booklet, designed to help people with Parkinson’s recognize non-motor symptoms such as cognitive impairment, sleep problems and compulsive behaviours and learn about treatments and strategies to manage them.

The 50-page booklet, available in English and French, is the result of a partnership between Parkinson Society Canada and the CIHR Institute of Neurosciences, Mental Health and Addiction. The author, Dr. Ronald Postuma is a researcher in neurosciences at the Research Institute of the McGill University Health Centre (MUHC) in Montreal.

Citing a typical example, Dr. Postuma says a man with Parkinson’s may present with a urinary problem that is initially thought to be a prostate issue when, in fact, it may be related to Parkinson’s.

"Many patients do not realize that urinary problems, constipation, insomnia and other symptoms are linked to Parkinson’s disease. As a result, they go untreated,” says Postuma who is also a neurologist at the MUHC and an Associate Professor of Neurology and Neurosurgery in the Faculty of Medicine at McGill University. “The booklet is a simple, pragmatic tool that I hope will improve patient care," he added.


Postuma says that the booklet is intended to help people with Parkinson’s identify their non-motor symptoms, record what they are experiencing using the Non-Motor Symptoms Questionnaire at the back of the booklet, and discuss these symptoms with their doctor. He cautions it is not intended to replace the advice or instruction of a professional healthcare practitioner, or to substitute medical care.

"This is an excellent example of the practical application of evidenced-based research that benefits clinical care," says Joyce Gordon, President & CEO, Parkinson Society Canada.


A Guide to the Non-Motor Symptoms of Parkinson’s Disease is available at www.parkinson.ca/NonMotorGuide.

Parkinson Society Canada’s national research program is dedicated to improving the quality of life for Canadians living with Parkinson’s. Its 10 regional partners and 240 chapters and support groups, have been providing education, support, and advocacy on behalf of over 100,000 Canadians living with Parkinson’s since 1965. To learn more visit www.parkinson.ca.

The Canadian Institutes of Health Research (CIHR) is the Government of Canada's health research investment agency. CIHR's mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened Canadian health care system. Composed of 13 Institutes, CIHR provides leadership and support to more than 14,100 health researchers and trainees across Canada. www.cihr-irsc.gc.ca